ArticleJournal of pain research2026
Intranasal Dexmedetomidine Combined with Local Infiltration Anesthesia for Perioperative Pain and Anxiety in PELD: A Retrospective Cohort Study.
Article in Journal of pain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Awake percutaneous endoscopic lumbar discectomy (PELD) preserves intraoperative patient feedback, but local infiltration anesthesia may inadequately control pain and anxiety during deeper procedural stages. Intranasal dexmedetomidine offers a noninvasive adjunct, although evidence in this setting remains limited. Methods: This two-center retrospective cohort study included 135 adults undergoing PELD with local infiltration anesthesia alone (n=80) or adjunctive intranasal dexmedetomidine (n=55). Pain and anxiety were assessed using the VAS and HADS-A, respectively. VAS scores were analyzed using a linear mixed model adjusted for study center and prespecified covariates. HADS-A scores were analyzed using ANCOVA adjusted for center, baseline HADS-A, and the same patient-level covariates. Results: After adjustment for center and prespecified baseline covariates, recorded pain was lower in the intranasal dexmedetomidine group at puncture, channel establishment, annular incision or nucleus removal, and the end of surgery. The largest adjusted difference occurred during annular incision or nucleus removal (mean difference, -1.81; 95% CI, -2.09 to -1.54; Holm-adjusted P<0.001). Rescue analgesia was recorded in 4 of 55 patients (7.3%) versus 18 of 80 (22.5%). Any adverse event was documented in 5 of 55 patients (9.1%) versus 8 of 80 (10.0%). Conclusion: In this retrospective cohort, intranasal dexmedetomidine was associated with lower recorded procedural pain and anxiety, lower hemodynamic peaks, and less frequent rescue analgesia. The observational design precludes causal inference and cannot establish safety regarding uncommon events. Prospective randomized evaluation is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.